J&J, Covax doses may see Africa, Caribbean meet 60% vaccine target
AU special Covid envoy Masiyiwa upbeat about jab prospects if delivery commitments for vaccines are met
If Johnson & Johnson (J&J) and the Covax Covid-19 vaccine-sharing initiative meet their commitments, then Africa and Caribbean nations may meet a target of inoculating about 800-million people, the head of the AU’s vaccine acquisition drive has said.
Caricom, a grouping of 15 Caribbean nations, has been given access to the Africa Vaccine Acquisition Task Team, which was set up by the AU to buy Covid-19 inoculations.
Covax has pledged to deliver doses to Africa, made up of a mix of single and double-shot regimes, and the AU has agreed to buy single-shot vaccines from J&J that will be made under licence by Aspen Pharmacare in SA and delivered over the next year.
“If the J&J shipments of 400-million are met, and the Covax make good on their 700-million doses, then we are at the 60% target,” the AU’s special envoy on Covid-19, Strive Masiyiwa, said in response to queries on Tuesday.
Africa is the least vaccinated continent, with just 1.1% of its 1.2-billion people fully vaccinated compared with about half the population of the US and the UK. The continent has struggled to procure vaccines, and deliveries from Covax have fallen short of projections after India halted exports.
Covax has to date delivered 95-million doses to 134 countries.
Some African nations have used donations or procured vaccines from China and Russia and an initial donation of 15-million doses from the US is ready for distribution.
Masiyiwa is a Zimbabwean telecommunications billionaire and philanthropist.
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.